RNA Transfection Kit for Immune Cells
Satreda LNP2006
A Powerful Tool for Immune Cell Research
The Satreda LNP2006 is engineered to revolutionize RNA delivery in immune cell lines, a cell category that has long posed challenges to researchers due to its inherent resistance to transfection. Designed specifically for widely used immune cell lines such as Jurkat, THP-1, and DC2.4, this kit empowers scientists with a robust, high-efficiency, and reproducible solution for RNA-based studies, gene editing, and vaccine development.
Next-Generation Lipid Design and Optimization
Built upon Satreda’s modular lipid library platform, LNP2006 integrates years of lipid chemistry expertise and advanced formulation engineering. Each component is fine-tuned to achieve optimal particle stability, membrane fusion capability, and biocompatibility. This meticulous design enables the delivery of RNA directly into immune cells with >90% transfection efficiency, significantly outperforming conventional chemical or physical methods such as electroporation or viral vectors.
Endogenous Delivery Mechanism for High Viability
At the core of LNP2006 is its endogenous transmembrane transport and endosomal escape mechanism, which allows RNA to enter immune cells naturally and efficiently without disrupting cellular integrity. This design not only enhances RNA uptake and expression but also ensures exceptional cell survival rates, maintaining physiological function even in sensitive immune cell types.
Broad Application Versatility
The LNP2006 kit supports the delivery of multiple RNA types — including mRNA, siRNA, and gRNA — offering unmatched flexibility for a variety of experimental and therapeutic applications. Researchers can leverage this platform for:
CRISPR/Cas9 gene editing, enabling precise genomic modifications in immune cell models.
mRNA vaccine development, for evaluating antigen expression and immune activation.
Functional immune assays, to study signaling pathways and cytokine regulation.
Ready-to-Use Simplicity and Reproducibility
The ready-to-use Satreda LNP formulation simplifies complex transfection workflows. RNA encapsulation is completed in just one minute, eliminating the need for specialized instruments, lengthy optimization steps, or harsh reagents. Each batch is standardized for consistency, ensuring reproducible transfection results across experiments and laboratories.
Accelerating Immunological Discovery
By combining high efficiency, low toxicity, and universal applicability, the Satreda LNP2006 kit provides an indispensable platform for immunology researchers. Whether optimizing CRISPR editing systems, testing mRNA vaccine constructs, or exploring immune signaling mechanisms, this technology transforms the way immune cell studies are conducted — accelerating discovery and enabling translational progress in next-generation immunotherapies.